4093-29-2Relevant articles and documents
ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-I' PATHWAY AND METHODS OF USE THEREOF
-
Page/Page column 81, (2020/03/05)
The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
As neuroprotective agents of pharmaceutical compounds
-
Paragraph 0713; 0714; 0715; 0716, (2019/06/26)
The invention discloses a medicinal compound as a neuroprotective agent. The medicinal compound is a neuronal nitric oxide synthase-postsynaptic density protein 95 (nNOS-PSD95) decoupling agent. The medicinal compound is a benzene ring derivative shown in the general formula (I) or its pharmaceutically acceptable salt. The invention further discloses a preparation method of the medicinal compound and a use of the medicinal compound in prevention and treatment on neuronal damage influence-caused diseases.
QUINAZOLINE-BASED KINASE INHIBITORS
-
Page/Page column 125; 126, (2016/04/26)
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.